Cargando…

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial

BACKGROUND: The aim of the Youth Depression Alleviation–Combined Treatment (YoDA-C) study is to determine whether antidepressant medication should be started as a first-line treatment for youth depression delivered concurrently with psychotherapy. Doubts about the use of medication have been raised...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davey, Christopher G, Chanen, Andrew M, Cotton, Sue M, Hetrick, Sarah E, Kerr, Melissa J, Berk, Michael, Dean, Olivia M, Yuen, Kally, Phelan, Mark, Ratheesh, Aswin, Schäfer, Miriam R, Amminger, G Paul, Parker, Alexandra G, Piskulic, Danijela, Harrigan, Susy, Mackinnon, Andrew J, Harrison, Ben J, McGorry, Patrick D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230740/ https://www.ncbi.nlm.nih.gov/pubmed/25370185 http://dx.doi.org/10.1186/1745-6215-15-425

Ejemplares similares

Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin
por: Berk, Michael, et al.
Publicado: (2020)

O10.8. A PLURIPOTENTIAL AT RISK MENTAL STATE: INITIAL RESULTS
por: Hartmann, Jessica A, et al.
Publicado: (2018)

Bipolar At-Risk Criteria and Risk of Bipolar Disorder Over 10 or More Years
por: Ratheesh, Aswin, et al.
Publicado: (2023)

Pluripotential Risk and Clinical Staging: Theoretical Considerations and Preliminary Data From a Transdiagnostic Risk Identification Approach
por: Hartmann, Jessica A., et al.
Publicado: (2021)

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis
por: Cotton, S. M., et al.
Publicado: (2019)

Cognitive ability and metabolic physical health in first-episode psychosis
por: Whitson, Sarah, et al.
Publicado: (2021)

Empirically driven transdiagnostic stages in the development of mood, anxiety and psychotic symptoms in a cohort of youth followed from birth
por: Ratheesh, Aswin, et al.
Publicado: (2023)

Spine Wars: The Lessons of YODA
por: Chapman, Jens
Publicado: (2013)

Yoda1 analogue (Dooku1) which antagonizes Yoda1‐evoked activation of Piezo1 and aortic relaxation
por: Evans, Elizabeth L, et al.
Publicado: (2018)

Very Low-Dose Risperidone in First-Episode Psychosis: A Safe and Effective Way to Initiate Treatment
por: McGorry, Patrick D., et al.
Publicado: (2011)

ACTION OF SAHACHARADI YODA IN KHANJA AND PANGU
por: Nair, P. Ramachandran, et al.
Publicado: (1984)

Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial
por: Allott, Kelly, et al.
Publicado: (2023)

Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
por: Nelson, Barnaby, et al.
Publicado: (2020)

The effectiveness of simple psychological and exercise interventions for high prevalence mental health problems in young people: a factorial randomised controlled trial
por: Parker, Alexandra G, et al.
Publicado: (2011)

Recent Meta-Analyses in the Clinical High Risk for Psychosis Population: Clinical Interpretation of Findings and Suggestions for Future Research
por: Nelson, Barnaby, et al.
Publicado: (2018)

S130. INCIDENCE OF FIRST EPISODE OF PSYCHOSIS IN AN AUSTRALIAN COHORT AND ASSOCIATIONS WITH NEIGHBOURHOOD CHARACTERISTICS
por: Eaton, Scott, et al.
Publicado: (2018)

Improving Mood with Physical ACTivity (IMPACT) trial: a cluster randomised controlled trial to determine the effectiveness of a brief physical activity behaviour change intervention on depressive symptoms in young people, compared with psychoeducation, in addition to routine clinical care within youth mental health services—a protocol study
por: Parker, Alexandra G., et al.
Publicado: (2019)

Speaker 3: Michael Berk, Australia
por: Michael, Berk, et al.
Publicado: (2016)

Online and Social Networking Interventions for the Treatment of Depression in Young People: A Systematic Review
por: Rice, Simon M, et al.
Publicado: (2014)

F130. INCREASED RISK OF PSYCHOTIC DISORDERS IN AFRICAN MIGRANTS TO AUSTRALIA
por: Downey, Linglee, et al.
Publicado: (2018)

Gender differences in first episode psychotic mania
por: Cotton, Sue M, et al.
Publicado: (2013)

Heschl’s gyrus duplication pattern and clinical characteristics in borderline personality disorder: A preliminary study
por: Takahashi, Tsutomu, et al.
Publicado: (2022)

Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study
por: Amminger, G. Paul, et al.
Publicado: (2015)

Fine grained event processing on HPCs with the ATLAS Yoda system
por: Calafiura, Paolo, et al.
Publicado: (2015)

Fine grained event processing on HPCs with the ATLAS Yoda system
por: Calafiura, Paolo, et al.
Publicado: (2015)

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
por: Amminger, G P, et al.
Publicado: (2015)

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study
por: Berger, M E, et al.
Publicado: (2017)

T121. RATES AND PREDICTORS OF RELAPSE FOLLOWING DISCONTINUATION OF ANTIPSYCHOTIC MEDICATION AFTER A FIRST EPISODE OF PSYCHOSIS
por: Bowtell, Meghan, et al.
Publicado: (2018)

Informing and Empowering Patients and Clinicians to Make Evidence-Supported Outcome-Based Decisions in Relation to SGLT2 Inhibitor Therapies: The Use of the Novel Years of Drug administration (YoDa) Concept
por: Varadhan, Lakshminarayanan, et al.
Publicado: (2022)

Yoda1 and phosphatidylserine exposure in red cells from patients with sickle cell anaemia
por: Wadud, R., et al.
Publicado: (2020)

Probing the gating mechanism of the mechanosensitive channel Piezo1 with the small molecule Yoda1
por: Lacroix, Jerome J., et al.
Publicado: (2018)

Yoda1’s energetic footprint on Piezo1 channels and its modulation by voltage and temperature
por: Wijerathne, Tharaka D., et al.
Publicado: (2022)

Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study
por: Kim, Sung-Wan, et al.
Publicado: (2016)

Is there a gap between recommended and ‘real world’ practice in the management of depression in young people? A medical file audit of practice
por: Hetrick, Sarah E, et al.
Publicado: (2012)

A mechanism for the activation of the mechanosensitive Piezo1 channel by the small molecule Yoda1
por: Botello-Smith, Wesley M., et al.
Publicado: (2019)

Erythrocyte glutathione levels as long-term predictor of transition to psychosis
por: Lavoie, S, et al.
Publicado: (2017)

PM396. Associations of obsessive–compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness
por: Kim, Sung-Wan, et al.
Publicado: (2016)

Tubeimoside I Antagonizes Yoda1-Evoked Piezo1 Channel Activation
por: Liu, Silin, et al.
Publicado: (2020)

¡Yo soy yo! /
por: Lukela
Publicado: (2017)

Overview and experience of the YODA Project with clinical trial data sharing after 5 years
por: Ross, Joseph S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jevnikm8hi856u6nluku6rihbh